equityflowunderstand the flow and follow it

Tubulis

Biotech · Munich, DE · tubulis.com

Develops ultra-stable antibody-drug conjugates for solid tumors with the P5 platform.

Founders

Dominik Schumacher (Germany · ♂) — A chemical biologist and MIT Innovator Under 35 who spun his academic work on protein conjugation out of FMP and LMU to co-found Tubulis in 2018 building next-generation antibody-drug conjugates.
Jonas Helma-Smets (Germany · ♂) — An antibody-engineering scientist who co-founded Tubulis and serves as Chief Scientific Officer, bringing over a decade of biotech and conjugation expertise.
Christian Hackenberger (Germany · ♂) — An FMP professor whose protein-chemistry research underpinned Tubulis's conjugation platform, co-founding the company as a scientific founder.
Heinrich Leonhardt (Germany · ♂) — An LMU molecular-biology professor whose lab work seeded Tubulis's technology, co-founding the ADC company in 2018.
Bjoern M Hock
Christian Groendahl

Team & hubs

People & leadership

Ingo Lehrke CBO at Tubulis & CEO at AlgiaxJonas Helma-Smets CSO and co-founder at Tubulis GmbHBjoern M Hock Founder and CEO, Lavaux Biotech consulting; CDO Tubulis GmbHChristian Groendahl Co-founder and CEO SNIPR BIOME, Chairman of the Supervisory Board Tubulis GmbH

Funding history

Date	Round	Amount
Oct 2025	Series C Tubulis closed a €308 million Series C led by Venrock Healthcare Capital Partners, the largest ever for a European biotech at this stage.	$357M

Investors

Tap an investor to see what else they have backed.

HTGF Venrock Healthcare Capital Partners Wellington Management

Other companies in Biotech

Imperagen Haga Bioscience Pixelgen Technologies Gallant Chai Discovery SNIPR Biome Cellbox Labs Scope Biosciences GenLumina Actithera NUCLIDIUM Anocca

Other companies in DE

NEURA Robotics Isar Aerospace GALVANY Pacifico Biolabs allO encosa Bayshore INXM NanoStruct Omnisent Proxima Fusion Peec AI

Other companies at Series C stage

99 Group 9fin A5X ACROVE AI21 Labs AMI ATAI Life Sciences Acceldata AccountsIQ ActiveCampaign Agicap AgomAb Therapeutics

Explore funding flow on EquityFlow →

Data is community-curated and may be incomplete.